Misc Supplies
Biohit IncWarner InstrumentsComputype Inc
Read More
Month: October 2011
MicroPhage, Cardinal Health Reach Marketing Agreement
MicroPhage Inc has reached an agreement with Cardinal Health granting exclusive rights to market the KeyPath MRSA/MSSA Blood Culture Test product line in North America.
Read MoreSysmex Releases New Version of Clinical Laboratory Management Software
Sysmex America Inc has released the newest version of its Sysmex WAM middleware software platform.
Read More
Automation
NorDiag Inc
Read MoreBioCurex Cancer Marker Blood Test More Accurate than FDA-Approved Free-PSA Test
BioCurex Inc’s RECAF cancer marker blood test has been shown to detect approximately 70% of stage I, 76% of stage II, 90% of stage III, and 100% of stage IV prostate cancers all with very high specificity.
Read More